Cash Flow Statement
Growth Metrics

Rb Global (RBA) Non-Current Deffered Revenue (2016 - 2017)

Quarterly Non-Current Deffered Revenue fell 32.48% to $2.9 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $2.9 million through Dec 2017, down 32.48% year-over-year, with the annual reading at $2.9 million for FY2017, 32.48% down from the prior year.

Rb Global filings provide 4 years of Non-Current Deffered Revenue readings, the most recent being $2.9 million for Q4 2017.

  • Non-Current Deffered Revenue hit $2.9 million in Q4 2017 for Rb Global, down from $4.2 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $8.9 million in Q2 2015 and bottomed at $2.9 million in Q4 2017.
  • Average Non-Current Deffered Revenue over 4 years is $6.1 million, with a median of $5.8 million recorded in 2014.
  • Peak annual rise in Non-Current Deffered Revenue hit 32.48% in 2017, while the deepest fall reached 32.48% in 2017.
  • Rb Global's Non-Current Deffered Revenue stood at $5.8 million in 2014, then surged by 49.54% to $8.7 million in 2015, then tumbled by 51.45% to $4.2 million in 2016, then tumbled by 32.48% to $2.9 million in 2017.
  • Per Business Quant, the three most recent readings for RBA's Non-Current Deffered Revenue are $2.9 million (Q4 2017), $4.2 million (Q4 2016), and $8.7 million (Q3 2015).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Relx 81.40 Bn 81.16 Bn - -
2 Rentokil Initial 79.56 Bn 78.10 Bn - -
3 Cintas 69.26 Bn 69.08 Bn 1.45 Bn -
4 Copart 33.09 Bn 28.01 Bn 971.24 Mn -
5 UL Solutions 20.56 Bn 20.32 Bn 381.00 Mn -
6 Global Payments 19.88 Bn 14.69 Bn 1.70 Bn -
7 Rb Global 19.08 Bn 18.89 Bn 869.50 Mn -
8 Aramark 13.57 Bn 13.16 Bn 426.35 Mn -
9 Amentum Holdings 5.65 Bn 5.74 Bn 345.00 Mn -
10 Dolby Laboratories 5.15 Bn 4.56 Bn 350.90 Mn 24.08 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2017 2.87 Mn
Dec 31, 2016 4.24 Mn